Cargando…
The Influence of HIV-1 Subtype in the Response to Therapeutic Dendritic Cell Vaccine
In the present study, we investigated the influence of HIV-1 subtype in the response to the dendritic cell (DC) therapeutic vaccine for HIV. HIV-1 viral load and TCD8+/TCD4+ cell counts for up to 48 weeks after vaccination. Out of 19 immunized subjects, 13 were infected by subtype B, 5 by subtype F,...
Autores principales: | Ferreira, Valéria, Moura, Patrícia, Crovella, Sergio, Sobhie Diaz, Ricardo, Castelo Filho, Adauto, Ximenes, Ricardo, Arraes, Luiz Cláudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534477/ https://www.ncbi.nlm.nih.gov/pubmed/23289053 http://dx.doi.org/10.2174/1874613601206010289 |
Ejemplares similares
-
Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis
por: Coelho, Antonio Victor Campos, et al.
Publicado: (2016) -
HIV-1 mother-to-child transmission in Brazil (1994–2016): a time series modeling
por: Campos Coelho, Antonio Victor, et al.
Publicado: (2019) -
Frequency of HLA B*5701 allele carriers in abacavir treated-HIV infected patients and controls from northeastern Brazil
por: Crovella, Sergio, et al.
Publicado: (2011) -
Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
por: Hunter, James R., et al.
Publicado: (2021) -
Antiretroviral Drug-Resistance Mutations on the Gag Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure
por: Hunter, James R., et al.
Publicado: (2022)